vs
帕可Bio（PACB）与Seer, Inc.（SEER）财务数据对比。点击上方公司名可切换其他公司
帕可Bio的季度营收约是Seer, Inc.的10.6倍（$44.6M vs $4.2M）。帕可Bio净利率更高（-90.4% vs -380.7%，领先290.3%）。帕可Bio同比增速更快（13.8% vs 5.0%）。Seer, Inc.自由现金流更多（$-11.1M vs $-19.9M）。过去两年Seer, Inc.的营收复合增速更高（17.1% vs 7.3%）
太平洋生物科学（加利福尼亚）公司是2004年成立的美国生物技术企业，专注于研发生产基因测序相关设备，还可实现新型实时生物观测。公司拥有两大核心测序平台：基于零模波导特性的单分子实时测序平台（SMRT），以及采用天然核苷酸、无损伤掺入完成DNA结合与延伸的结合测序技术（SBB）平台。
Seer, Inc.是一家总部位于美国加利福尼亚州雷德伍德城的生物技术企业，成立于2017年，专注于开发蛋白质组学研究领域的相关技术，目前在生物科研技术开发领域开展业务。
PACB vs SEER — 直观对比
营收规模更大
PACB
是对方的10.6倍
$4.2M
营收增速更快
PACB
高出8.8%
5.0%
净利率更高
PACB
高出290.3%
-380.7%
自由现金流更多
SEER
多$8.8M
$-19.9M
两年增速更快
SEER
近两年复合增速
7.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $44.6M | $4.2M |
| 净利润 | $-40.4M | $-16.0M |
| 毛利率 | 37.1% | 52.0% |
| 营业利润率 | -92.3% | -413.8% |
| 净利率 | -90.4% | -380.7% |
| 营收同比 | 13.8% | 5.0% |
| 净利润同比 | -1802.7% | 26.4% |
| 每股收益（稀释后） | $-0.11 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PACBSEER
| Q4 25 | $44.6M | $4.2M | ||
| Q3 25 | $38.4M | $4.1M | ||
| Q2 25 | $39.8M | $4.1M | ||
| Q1 25 | $37.2M | $4.2M | ||
| Q4 24 | $39.2M | $4.0M | ||
| Q3 24 | $40.0M | $4.0M | ||
| Q2 24 | $36.0M | $3.1M | ||
| Q1 24 | $38.8M | $3.1M |
净利润PACBSEER
| Q4 25 | $-40.4M | $-16.0M | ||
| Q3 25 | $-38.0M | $-18.2M | ||
| Q2 25 | $-41.9M | $-19.4M | ||
| Q1 25 | $-426.1M | $-19.9M | ||
| Q4 24 | $2.4M | $-21.7M | ||
| Q3 24 | $-60.7M | $-21.3M | ||
| Q2 24 | $-173.3M | $-22.9M | ||
| Q1 24 | $-78.2M | $-20.7M |
毛利率PACBSEER
| Q4 25 | 37.1% | 52.0% | ||
| Q3 25 | 41.4% | 51.2% | ||
| Q2 25 | 36.9% | 52.1% | ||
| Q1 25 | -3.7% | 49.0% | ||
| Q4 24 | 25.6% | 50.6% | ||
| Q3 24 | 25.0% | 48.1% | ||
| Q2 24 | 16.5% | 56.3% | ||
| Q1 24 | 29.1% | 44.4% |
营业利润率PACBSEER
| Q4 25 | -92.3% | -413.8% | ||
| Q3 25 | -101.1% | -469.4% | ||
| Q2 25 | -112.8% | -506.8% | ||
| Q1 25 | -1154.5% | -493.0% | ||
| Q4 24 | -390.1% | -587.2% | ||
| Q3 24 | -160.3% | -603.3% | ||
| Q2 24 | -488.3% | -882.0% | ||
| Q1 24 | -209.6% | -821.7% |
净利率PACBSEER
| Q4 25 | -90.4% | -380.7% | ||
| Q3 25 | -98.9% | -442.5% | ||
| Q2 25 | -105.4% | -479.5% | ||
| Q1 25 | -1146.8% | -474.4% | ||
| Q4 24 | 6.0% | -543.6% | ||
| Q3 24 | -151.9% | -529.0% | ||
| Q2 24 | -481.3% | -743.8% | ||
| Q1 24 | -201.4% | -674.5% |
每股收益（稀释后）PACBSEER
| Q4 25 | $-0.11 | — | ||
| Q3 25 | $-0.13 | — | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-1.44 | — | ||
| Q4 24 | $-0.44 | — | ||
| Q3 24 | $-0.22 | $-0.35 | ||
| Q2 24 | $-0.64 | $-0.35 | ||
| Q1 24 | $-0.29 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $279.5M | $47.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $5.3M | $259.3M |
| 总资产 | $784.1M | $296.1M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PACBSEER
| Q4 25 | $279.5M | $47.3M | ||
| Q3 25 | $298.7M | $45.0M | ||
| Q2 25 | $314.7M | $37.9M | ||
| Q1 25 | $343.1M | $52.4M | ||
| Q4 24 | $389.9M | $40.8M | ||
| Q3 24 | $471.1M | $37.6M | ||
| Q2 24 | $509.8M | $31.9M | ||
| Q1 24 | $561.9M | $54.4M |
股东权益PACBSEER
| Q4 25 | $5.3M | $259.3M | ||
| Q3 25 | $36.1M | $271.8M | ||
| Q2 25 | $61.5M | $288.3M | ||
| Q1 25 | $91.6M | $311.0M | ||
| Q4 24 | $506.6M | $327.6M | ||
| Q3 24 | $453.1M | $344.7M | ||
| Q2 24 | $492.7M | $364.7M | ||
| Q1 24 | $649.0M | $383.6M |
总资产PACBSEER
| Q4 25 | $784.1M | $296.1M | ||
| Q3 25 | $803.2M | $308.6M | ||
| Q2 25 | $825.5M | $322.5M | ||
| Q1 25 | $860.8M | $347.3M | ||
| Q4 24 | $1.3B | $366.6M | ||
| Q3 24 | $1.5B | $383.4M | ||
| Q2 24 | $1.5B | $406.6M | ||
| Q1 24 | $1.7B | $422.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.1M | $-10.8M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | $-11.1M |
| 自由现金流率自由现金流/营收 | -44.6% | -264.2% |
| 资本支出强度资本支出/营收 | 1.9% | 7.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-114.1M | $-46.2M |
8季度趋势，按日历期对齐
经营现金流PACBSEER
| Q4 25 | $-19.1M | $-10.8M | ||
| Q3 25 | $-18.7M | $-7.6M | ||
| Q2 25 | $-29.4M | $-14.7M | ||
| Q1 25 | $-44.1M | $-11.4M | ||
| Q4 24 | $-30.6M | $-11.5M | ||
| Q3 24 | $-45.5M | $-14.1M | ||
| Q2 24 | $-54.3M | $-10.1M | ||
| Q1 24 | $-75.7M | $-10.5M |
自由现金流PACBSEER
| Q4 25 | $-19.9M | $-11.1M | ||
| Q3 25 | $-18.8M | $-7.8M | ||
| Q2 25 | $-29.9M | $-15.2M | ||
| Q1 25 | $-45.4M | $-12.1M | ||
| Q4 24 | $-32.3M | $-12.0M | ||
| Q3 24 | $-46.3M | $-16.3M | ||
| Q2 24 | $-55.7M | $-11.2M | ||
| Q1 24 | $-79.6M | $-11.2M |
自由现金流率PACBSEER
| Q4 25 | -44.6% | -264.2% | ||
| Q3 25 | -48.9% | -190.5% | ||
| Q2 25 | -75.3% | -375.9% | ||
| Q1 25 | -122.3% | -287.1% | ||
| Q4 24 | -82.3% | -299.8% | ||
| Q3 24 | -115.7% | -404.7% | ||
| Q2 24 | -154.8% | -366.0% | ||
| Q1 24 | -205.0% | -365.6% |
资本支出强度PACBSEER
| Q4 25 | 1.9% | 7.0% | ||
| Q3 25 | 0.2% | 6.9% | ||
| Q2 25 | 1.4% | 14.0% | ||
| Q1 25 | 3.7% | 15.6% | ||
| Q4 24 | 4.1% | 13.4% | ||
| Q3 24 | 2.0% | 54.4% | ||
| Q2 24 | 4.1% | 38.2% | ||
| Q1 24 | 10.0% | 24.6% |
现金转化率PACBSEER
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -12.93× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PACB
| Products | $39.0M | 87% |
| Service And Other | $5.7M | 13% |
SEER
暂无分部数据
